AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion


AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.

You May Also Like

Oil prices extend bounce but remain on track for weekly losses on demand worries

Oil futures rose Friday, extending a bounce from the previous session, but…

‘I’m fed up’: My selfish mother-in-law has controlled me for 30 years. How can I regain my power?

“I’m almost 50 years old. Enough is enough. I am exhausted by…

Retiring abroad is touted as a money saver — here’s why it isn’t always cheaper

Taxes, investments, healthcare — everything adds up. Here’s how to plan now…

We’re living in Los Angeles with about $2.4 million. I want to retire at 55 in five years. ‘Is retirement a pipe dream?’

‘We probably just have enough for my only daughter’s college expenses in…